IRIDEX CORP
Financial highlights
| Metric | FY 01/03/26 | FY 12/28/24 | FY 12/30/23 | FY 12/31/22 | FY 01/01/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $52.7M | $48.7M | $51.9M | $57.0M | $53.9M |
| Cost of revenue | $33.4M | $29.2M | $30.1M | $31.6M | $31.1M |
| Gross profit | $19.2M | $19.5M | $21.8M | $25.4M | $22.8M |
| Research and development | $3.7M | $5.4M | $6.8M | $7.2M | $6.9M |
| Operating expenses | $21.8M | $27.8M | $31.8M | $32.9M | $30.4M |
| Operating income | -$2.6M | -$8.3M | -$10.0M | -$7.5M | -$7.5M |
| Pretax income | -$4.4M | -$8.8M | -$9.5M | -$7.5M | -$5.2M |
| Income tax expense | $57,000 | $68,000 | $90,000 | $65,000 | $40,000 |
| Net income | -$4.4M | -$8.9M | -$9.6M | -$7.5M | -$5.2M |
| Balance Sheet | |||||
| Cash and equivalents | $6.0M | $2.4M | $7.0M | $13.9M | $23.9M |
| Current assets | $25.3M | $23.6M | $27.4M | $35.8M | $42.3M |
| Total assets | $29.2M | $29.1M | $34.4M | $42.3M | $48.7M |
| Current liabilities | $13.2M | $16.6M | $13.0M | $12.5M | $12.6M |
| Total liabilities | $24.2M | $27.0M | $24.9M | $25.1M | $25.4M |
| Stockholders' equity | $4.9M | $2.1M | $9.5M | $17.2M | $23.3M |
| Cash Flow Statement | |||||
| Cash from operations | -$2.1M | -$7.3M | -$6.7M | -$9.5M | $8.2M |
| Depreciation and amortization | $200,000 | $244,000 | $277,000 | $257,000 | $640,000 |
| Stock-based compensation | $775,000 | $1.2M | $1.6M | $1.6M | $1.6M |
| Capital expenditure | $143,000 | $13,000 | $109,000 | $286,000 | $213,000 |
| Free cash flow | -$2.3M | -$7.3M | -$6.9M | -$9.8M | $8.0M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 17.4M · Free float 4.9%
Annual filing data through FY ended January 3, 2026; float as of July 11, 2026.